标题
Dengue viruses and promising envelope protein domain III-based vaccines
作者
关键词
Dengue virus, Envelope protein, Chimeric vaccine, Disease, Immunogenicity
出版物
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Volume 102, Issue 7, Pages 2977-2996
出版商
Springer Nature
发表日期
2018-02-22
DOI
10.1007/s00253-018-8822-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys
- (2017) Georg F. Bischof et al. JOURNAL OF VIROLOGY
- Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes
- (2017) Laura Lazo Vázquez et al. VIRAL IMMUNOLOGY
- Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
- (2017) Xiaoyan Zheng et al. Frontiers in Cellular and Infection Microbiology
- A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus
- (2017) Hamed Haddad Kashani et al. Frontiers in Cellular and Infection Microbiology
- Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice
- (2017) Alice F. Versiani et al. JOURNAL OF NANOBIOTECHNOLOGY
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
- (2016) Niyati Khetarpal et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
- (2016) Ankur Poddar et al. BMC BIOTECHNOLOGY
- Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1
- (2016) Xin Yu Chen et al. MICROBIOLOGY AND IMMUNOLOGY
- Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes
- (2016) Mi-Young Kim et al. PLANT MOLECULAR BIOLOGY
- Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
- (2016) Chen-Yi Chiang et al. VACCINE
- Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
- (2016) Sean P. McBurney et al. VACCINE
- Status of vaccine research and development of vaccines for dengue
- (2016) Kirsten S. Vannice et al. VACCINE
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
- (2016) Chen-Yi Chiang et al. Scientific Reports
- Purification of Antibacterial CHAPK Protein Using a Self-Cleaving Fusion Tag and Its Activity Against Methicillin-Resistant Staphylococcus aureus
- (2016) Elahe Seyed Hosseini et al. Probiotics and Antimicrobial Proteins
- A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys
- (2015) Edith Suzarte et al. INTERNATIONAL IMMUNOLOGY
- Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen
- (2015) Antônio J. S. Gonçalves et al. PLoS Neglected Tropical Diseases
- A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice
- (2014) Alienys Izquierdo et al. ARCHIVES OF VIROLOGY
- Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
- (2014) Edith Suzarte et al. ARCHIVES OF VIROLOGY
- The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2
- (2014) Lázaro Gil et al. IMMUNOLOGY AND CELL BIOLOGY
- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
- (2013) Hsin-Wei Chen et al. ARCHIVES OF VIROLOGY
- Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III
- (2013) Chen-Yi Chiang et al. MICROBES AND INFECTION
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae
- (2013) Ngoc-Luong Nguyen et al. PROTEIN EXPRESSION AND PURIFICATION
- Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice
- (2013) Nancy Coconi-Linares et al. VACCINE
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus
- (2012) Ernesto Marcos et al. ARCHIVES OF VIROLOGY
- Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
- (2012) Jie Yang et al. CANADIAN JOURNAL OF MICROBIOLOGY
- M Cell-Targeting Ligand and Consensus Dengue Virus Envelope Protein Domain III Fusion Protein Production in Transgenic Rice Calli
- (2012) Tae-Geum Kim et al. MOLECULAR BIOTECHNOLOGY
- Expression of a consensus dengue virus envelope protein domain III in transgenic callus of rice
- (2012) Mi-Young Kim et al. PLANT CELL TISSUE AND ORGAN CULTURE
- Expression, Purification and Evaluation of Diagnostic Potential and Immunogenicity of Dengue Virus Type 3 Domain III Protein
- (2012) Pradeep B.J. Reddy et al. PROTEIN AND PEPTIDE LETTERS
- Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
- (2012) Katherine L. Williams et al. VIROLOGY
- Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
- (2012) Chen-Yi Chiang et al. PLoS Neglected Tropical Diseases
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
- (2012) Oliver J. Brady et al. PLoS Neglected Tropical Diseases
- Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
- (2012) Upasana Arora et al. JOURNAL OF NANOBIOTECHNOLOGY
- Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli
- (2011) Nagesh K. Tripathi et al. Biotechnology Journal
- The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
- (2011) Iris Valdés et al. Clinical and Vaccine Immunology
- A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
- (2011) V.J. Gunther et al. VACCINE
- Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
- (2010) Laura Lazo et al. ARCHIVES OF VIROLOGY
- Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization
- (2010) Juliana Helena Chávez et al. BIOLOGICALS
- Review of dengue virus and the development of a vaccine
- (2010) Sarah Murrell et al. BIOTECHNOLOGY ADVANCES
- Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
- (2010) Raphaël M. Zellweger et al. Cell Host & Microbe
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in Mice
- (2010) J. Zlatkovic et al. JOURNAL OF VIROLOGY
- A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
- (2010) Chih-Hsiang Leng et al. MOLECULAR IMMUNOLOGY
- A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- (2010) Olivia K.T. Block et al. VACCINE
- Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
- (2010) Samantha Brandler et al. VACCINE
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus
- (2010) Deqing Zhang et al. VACCINE
- Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection
- (2010) Qun Zheng et al. VACCINE
- A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection
- (2010) Danielle Malta Lima et al. VACCINE
- A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
- (2010) Gunther Spohn et al. Virology Journal
- Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis
- (2010) Gilma Sánchez-Burgos et al. VIRUS RESEARCH
- Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006
- (2010) Jessica R. Fried et al. PLoS Neglected Tropical Diseases
- Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
- (2010) Scott J. Balsitis et al. PLoS Pathogens
- Dengue virus-induced hemorrhage in a nonhuman primate model
- (2009) N. Onlamoon et al. BLOOD
- On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
- (2009) R. Rajamanonmani et al. JOURNAL OF GENERAL VIROLOGY
- Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion
- (2009) V. Nayak et al. JOURNAL OF VIROLOGY
- Modulation of intein activity by its neighboring extein substrates
- (2009) G. Amitai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
- (2009) Saima Khanam et al. VACCINE
- Development of a novel DNA SynCon™ tetravalent dengue vaccine that elicits immune responses against four serotypes
- (2009) Mathura P. Ramanathan et al. VACCINE
- A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
- (2009) Hsin-Wei Chen et al. VACCINE
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
- (2008) L BERNARDO et al. ANTIVIRAL RESEARCH
- Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
- (2008) Laura Lazo et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Production and characterization of recombinant dengue virus type 4 envelope domain III protein
- (2008) N TRIPATHI et al. JOURNAL OF BIOTECHNOLOGY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
- (2008) R. Suzuki et al. JOURNAL OF VIROLOGY
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model
- (2008) Chiou-Feng Lin et al. LABORATORY INVESTIGATION
- A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
- (2008) Chih-Hsiang Leng et al. MICROBES AND INFECTION
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
- Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
- (2008) Joseph E. Blaney et al. VACCINE
- Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen
- (2008) Adrian C.N. Sim et al. VACCINE
- Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
- (2008) J. Pradeep Babu et al. VACCINE
- “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
- (2008) Robert Edelman et al. VACCINE
- Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis
- (2008) Iris Valdés et al. VACCINE
- Towards a dengue vaccine: Progress to date and remaining challenges
- (2007) Bruno Guy et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now